Nigro Carlos Alberto, Borsini Eduardo Enrique, Dibur Eduardo, Larrateguy Luis Dario, Cazaux Alexis, Elias Carlos, de-la-Vega Marcelino, Berrozpe Cecilia, Maggi Silvana, Grandval Sofía, Cambursano Hugo, Visentini Daniela, Criniti Juan, Nogueira Facundo
Hospital Alemán, Sleep Lab, Pneumonology - Buenos Aires - Buenos Aires - Argentina.
Hospital Británico, Sleep Lab, Pneumonology - Buenos Aires - Buenos Aires - Argentina.
Sleep Sci. 2019 Oct-Dec;12(4):249-256. doi: 10.5935/1984-0063.20190089.
The usefulness of pulse oximetry for the management of obstructive sleep apnea is controversial. The aim of this study was to assess the accuracy for indication of Continuous Positive Airway Pressure (CPAP) treatment in patients with suspected obstructive sleep apnea (OSA) based on clinical and oximetry data as compared to polysomnography (PSG).
This multicenter observational study involved seven sleep laboratories. Patients with suspicion of OSA who completed a standardized sleep questionnaire and a diagnostic PSG were enrolled. Eight observers logged on to a website independently and blindly. Seven observers only accessed the clinical data, curve and pulse oximetry results (Os-SO2-test method), while the eighth observer had full access to all indicators of PSG (O-PSG-reference method). Once observers assessed the information available on the website, they had to choose between three CPAP treatment options (yes/no/do not know) based on their knowledge and criteria.
411 subjects (228 men), median age 54 years, were available for evaluation. Os-SO2 had lower sensitivity (S), greater specificity (Sp) and positive likelihood ratio (PLR) to prescribe CPAP in patients more symptomatic (Epworth Sleepiness Scale-ESS > 10 or comorbidities) than those with fewer symptoms (ESS < 11 without comorbidities) (S 45-75% versus 45-91%, 0.028); Sp 93.8-100% versus 68.5-96.6%, 0.004; PLR > 10 versus 2.9-17, <0.01).
Due to its low false positive rate, a strategy based on pulse oximetry and clinical data was a consistent tool to indicate CPAP treatment in most symptomatic patients with a suspicion of OSA.
脉搏血氧饱和度测定法在阻塞性睡眠呼吸暂停管理中的效用存在争议。本研究的目的是基于临床和血氧饱和度测定数据,与多导睡眠图(PSG)相比,评估疑似阻塞性睡眠呼吸暂停(OSA)患者持续气道正压通气(CPAP)治疗指征的准确性。
这项多中心观察性研究涉及七个睡眠实验室。纳入完成标准化睡眠问卷和诊断性PSG的疑似OSA患者。八名观察者独立且盲法登录一个网站。七名观察者仅获取临床数据、曲线和脉搏血氧饱和度测定结果(Os-SO2测试法),而第八名观察者可全面获取PSG的所有指标(O-PSG参考法)。一旦观察者评估了网站上可用的信息,他们必须根据自己的知识和标准在三种CPAP治疗选项(是/否/不知道)中做出选择。
411名受试者(228名男性),中位年龄54岁,可供评估。与症状较少(Epworth嗜睡量表-ESS<11且无合并症)的患者相比,Os-SO2在症状更明显(Epworth嗜睡量表-ESS>10或有合并症)的患者中开具CPAP的敏感性(S)较低、特异性(Sp)较高和阳性似然比(PLR)较高(S分别为45-75%对45-91%,P<0.028);Sp分别为93.8-100%对68.5-96.6%,P<0.004;PLR>10对2.9-17,P<0.01)。
由于其假阳性率低,基于脉搏血氧饱和度测定法和临床数据的策略是在大多数疑似OSA的症状明显患者中指示CPAP治疗的一致工具。